Zobrazeno 1 - 10
of 501
pro vyhledávání: '"osteoporosi"'
Publikováno v:
NSC Nursing, Vol 4, Iss 2, Pp 15-30 (2018)
Introduzione In Italia circa 3,5 milioni di donne ed 1 milione di uomini sono affetti da osteoporosi. Si tratta di una condizione emergente a causa dell’invecchiamento della popolazione, che colpisce il 50% circa delle donne dopo i 70 anni, a segu
Externí odkaz:
https://doaj.org/article/7407aca253434d70a475612a07b9a2ea
Autor:
Guido Zavatta, Bart L. Clarke
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 50:251-273
Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis; nonetheless, it remains an undertreated condition. Transplantation-induced osteoporosis encompasses a broad range of unique pathogenetic features with distinct ch
Autor:
Inge Groenendijk, Pol Grootswagers, Aurelia Santoro, Claudio Franceschi, Alberto Bazzocchi, Nathalie Meunier, Aurélie Caille, Corinne Malpuech‐Brugere, Agata Bialecka‐Debek, Barbara Pietruszka, Susan Fairweather‐Tait, Amy Jennings, Lisette C.P.G.M. de Groot
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, 2023, 14 (1), pp.116-125. ⟨10.1002/jcsm.13111⟩
Journal of cachexia, sarcopenia and muscle, 14(1), 116-125
Journal of cachexia, sarcopenia and muscle 14 (2023) 1
Journal of Cachexia, Sarcopenia and Muscle, 2023, 14 (1), pp.116-125. ⟨10.1002/jcsm.13111⟩
Journal of cachexia, sarcopenia and muscle, 14(1), 116-125
Journal of cachexia, sarcopenia and muscle 14 (2023) 1
Background: There are several mechanisms via which increased protein intake might maintain or improve bone mineral density (BMD), but current evidence for an association or effect is inconclusive. The objectives of this study were to investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3e5a34f879f7b6063c0fa6b688f6e3
https://hal.inrae.fr/hal-04032256/document
https://hal.inrae.fr/hal-04032256/document
Publikováno v:
Frontiers in Physiology. 14
Autor:
Francesca Salamanna, Deyanira Contartese, Alberto Ruffilli, Francesca Barile, Daniele Bellavia, Laura Marchese, Marco Manzetti, Giovanni Viroli, Cesare Faldini, Gianluca Giavaresi
Background: Osteosarcopenia, a combination of osteopenia/osteoporosis and sarcopenia,is a common condition among older adults. While numerous studies and meta-analyses have beenconducted on osteoporosis biomarkers, biomarker utility in osteosarcopeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9229890427a43675b35c06166447e8ec
https://hdl.handle.net/11585/917949
https://hdl.handle.net/11585/917949
Osteoporosis is called a silent disease because bone fragility manifests itself to the patient only in an advanced state, through fracture and pain. Medical and industry leaders recognize that the current golden standard diagnostic method, densitomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2917526a227662a0297cf1066bc6577
https://hdl.handle.net/11368/3043738
https://hdl.handle.net/11368/3043738
Publikováno v:
Scientia
Romosozumab; Osteoporosi greu; Dones postmenopàusiques Romosozumab; Osteoporosis grave; Mujeres posmenopáusicas Romosozumab; Severe osteoporosis; Postmenopausal women L’osteoporosi (OP) és una malaltia òssia caracteritzada per una pèrdua progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::94a8f709eda3d47fcac258b150b0327d
https://hdl.handle.net/11351/9026
https://hdl.handle.net/11351/9026
Publikováno v:
Oral; Volume 2; Issue 4; Pages: 274-285
Background: Medication-Related Osteonecrosis of the Jaw (MRONJ) is an adverse drug reaction mainly associated to bone modifying agents (BMAs). Breast cancer (BC) is the most frequent cancer worldwide. Its therapy can cause cancer treatment-induced bo
Autor:
Nasto, Luigi Aurelio, Jannelli, Eugenio, Cipolloni, Valerio, Piccone, Luca, Cattolico, Alessandro, Santagada, Alessandro, Pripp, Charlotte, Panni, Alfredo Schiavone, Pola, Enrico
Publikováno v:
Orthop Rev (Pavia)
The management of vertebral compression fractures (VCFs) is based on conservative treatment and minimally invasive vertebral augmentation procedures. However, the role of vertebral augmentation is now being questioned by clinical trials and extensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c18d622faf766afc8cb41e8295cd23
https://europepmc.org/articles/PMC9568420/
https://europepmc.org/articles/PMC9568420/
Autor:
Maria Rizzo, Gisella Tammaro, Amedeo Guarino, Morena Basso, Andrea Cozzolino, Massimo Mariconda
Publikováno v:
Orthop Rev (Pavia)
Background Osteoporosis is responsible for fragility fractures, which are associated with impaired quality of life (QoL) and disability. Objective The aim of the study was to evaluate the QoL in patients affected by osteoporosis and possible determin